Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Melbourne, VIC, Australia.
Quality Use of Medicines and Pharmacy Research Centre, Clinical and Health Sciences, University of South Australia, Adelaide, SA, Australia.
Age Ageing. 2023 Jan 8;52(1). doi: 10.1093/ageing/afac335.
BACKGROUND: people living with cognitive impairment commonly take multiple medications including potentially inappropriate medications (PIMs), which puts them at risk of medication related harms. AIMS: to explore willingness to have a medication deprescribed of older people living with cognitive impairment (dementia or mild cognitive impairment) and multiple chronic conditions and assess the relationship between willingness, patient characteristics and belief about medications. METHODS: cross-sectional study using results from the revised Patients' Attitudes Towards Deprescribing questionnaire (rPATDcog) collected as baseline data in the OPTIMIZE study, a pragmatic, cluster-randomised trial educating patients and clinicians about deprescribing. Eligible participants were 65+, diagnosed with dementia or mild cognitive impairment, and prescribed at least five-long-term medications. RESULTS: the questionnaire was mailed to 1,409 intervention patients and 553 (39%) were returned and included in analysis. Participants had a mean age of 80.1 (SD 7.4) and 52.4% were female. About 78.5% (431/549) of participants said that they would be willing to have one of their medications stopped if their doctor said it was possible. Willingness to deprescribe was negatively associated with getting stressed when changes are made and with previously having a bad experience with stopping a medication (P < 0.001 for both). CONCLUSION: most older people living with cognitive impairment are willing to deprescribe. Addressing previous bad experiences with stopping a medication and stress when changes are made to medications may be key points to discuss during deprescribing conversations.
背景:患有认知障碍的人通常会服用多种药物,包括潜在不适当的药物(PIMs),这使他们面临药物相关伤害的风险。
目的:探索患有认知障碍(痴呆或轻度认知障碍)和多种慢性疾病的老年人是否愿意减少用药,并评估其与意愿、患者特征和对药物的信念之间的关系。
方法:这是一项横断面研究,使用 OPTIMIZE 研究中作为基线数据收集的修订版患者对停药态度问卷(rPATDcog)的结果,该研究是一项关于教育患者和临床医生进行停药的实用、集群随机试验。合格的参与者年龄在 65 岁以上,被诊断为痴呆或轻度认知障碍,并开了至少五种长期药物。
结果:问卷邮寄给了 1409 名干预组患者,其中 553 名(39%)返回并纳入分析。参与者的平均年龄为 80.1(7.4)岁,52.4%为女性。约 78.5%(431/549)的参与者表示,如果他们的医生说有可能,他们愿意停止服用一种药物。愿意减少用药与当药物发生变化时感到压力以及之前有过停药不良经历呈负相关(两者均 P<0.001)。
结论:大多数患有认知障碍的老年人愿意减少用药。解决停药不良经历和药物变化时的压力可能是停药对话中需要讨论的关键点。
J Am Geriatr Soc. 2019-2-13
Int J Environ Res Public Health. 2022-9-11
J Am Geriatr Soc. 2023-10
J Am Geriatr Soc. 2022-6
J Gerontol A Biol Sci Med Sci. 2022-5-5
Expert Rev Clin Pharmacol. 2021-11
Patient Educ Couns. 2022-3
Res Social Adm Pharm. 2021-4
Expert Opin Drug Metab Toxicol. 2021-1